5/22/25 13:19  | 5/21/25  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | M.d | 48 | 3.76 | 0 | 13 | 1 | 1,160 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/30/25 12:07  | 1/29/25  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S | -24 | 29.52 | 0 | -1 | 0 | 1,148 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/23/25 15:25  | 1/22/25  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S | -120 | 30.43 | 0 | -4 | 0 | 1,149 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/21/25 16:02  | 1/17/25  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S | -22 | 29.96 | 0 | -1 | 0 | 1,152 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/14/25 16:14  | 1/13/25  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S | -66 | 28.70 | 0 | -2 | 0 | 1,138 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/21/24 16:03  | 5/20/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | M.d | 92 | 3.76 | 0 | 25 | 2 | 1,140 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/9/24 17:15  | 5/8/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | M.d | 340 | 4.31 | 0 | 79 | 8 | 1,116 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/9/24 17:15  | 5/8/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S.d | -3,342 | 42.35 | 0 | -79 | -7 | 1,116 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/9/24 16:25  | 4/8/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | M.d | 260 | 3.76 | 0 | 69 | 7 | 1,116 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/9/24 16:25  | 4/8/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S.d | -3,744 | 54.17 | 0 | -69 | -6 | 1,116 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/11/24 16:08  | 3/8/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | M.d | 254 | 3.67 | 0 | 69 | 7 | 1,116 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/11/24 16:08  | 3/8/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S.d | -4,298 | 62.19 | 0 | -69 | -6 | 1,116 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/13/24 16:43  | 2/12/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S | -78 | 67.77 | 0 | -1 | 0 | 1,116 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/31/24 16:21  | 1/29/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S | -56 | 64.14 | 0 | -1 | 0 | 1,117 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/23/24 18:03  | 1/22/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S | -254 | 65.00 | 0 | -4 | 0 | 1,118 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/17/24 16:47  | 1/16/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S.d | -109 | 66.81 | 0 | -2 | 0 | 1,122 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/15/23 16:10  | 11/14/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | M.d | 169 | 3.76 | 0 | 45 | 4 | 1,117 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/9/23 16:18  | 11/8/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | M.d | 47 | 2.67 | 0 | 17 | 2 | 1,072 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/9/23 16:18  | 11/8/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S.d | -567 | 47.27 | 0 | -12 | -1 | 1,072 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/10/23 16:26  | 10/9/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | M.d | 49 | 2.67 | 0 | 19 | 2 | 1,066 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/10/23 16:26  | 10/9/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S.d | -485 | 40.38 | 0 | -12 | -1 | 1,066 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/11/23 16:58  | 9/8/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | M.d | 49 | 2.67 | 0 | 19 | 2 | 1,060 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/11/23 16:58  | 9/8/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S.d | -514 | 42.87 | 0 | -12 | -1 | 1,060 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/9/23 16:08  | 8/8/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | M.d | 49 | 2.67 | 0 | 19 | 2 | 1,053 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/9/23 16:08  | 8/8/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S.d | -284 | 23.66 | 0 | -12 | -1 | 1,053 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/11/23 17:37  | 7/10/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | M.d | 49 | 2.67 | 0 | 19 | 2 | 1,047 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/11/23 17:37  | 7/10/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S.d | -1,015 | 84.55 | 0 | -12 | -1 | 1,047 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/9/23 16:40  | 6/8/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | M.d | 49 | 2.67 | 0 | 19 | 2 | 1,040 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/9/23 16:40  | 6/8/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S.d | -1,096 | 91.35 | 0 | -12 | -1 | 1,040 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/9/23 17:02  | 5/8/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | M.d | 49 | 2.67 | 0 | 19 | 2 | 1,034 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/9/23 17:02  | 5/8/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S.d | -1,109 | 92.39 | 0 | -12 | -1 | 1,034 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/11/23 16:20  | 4/10/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | M.d | 49 | 2.67 | 0 | 19 | 2 | 1,027 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/11/23 16:20  | 4/10/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S.d | -939 | 78.21 | 0 | -12 | -1 | 1,027 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/10/23 17:18  | 3/8/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | M.d | 49 | 2.67 | 0 | 19 | 2 | 1,021 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/10/23 17:18  | 3/8/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S.d | -765 | 63.79 | 0 | -12 | -1 | 1,021 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/10/23 17:00  | 2/8/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | M.d | 49 | 2.67 | 0 | 19 | 2 | 1,007 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/10/23 17:00  | 2/8/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Deschatelets Pascal | MA | O | Chief Sc | S.d | -653 | 54.45 | 0 | -12 | -1 | 1,007 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |